Presentation - Fostering innovation in cardiovascular diseases with digitalisationand AI (K. Azer)
Presentation - Fostering innovation in cardiovascular diseases with digitalisationand AI (K. Azer)
Presentation - Fostering innovation in cardiovascular diseases with digitalisationand AI (K. Azer)
Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Revision: 3, Status: Authorised
Presentation - Experience gained and lessons learned from recent and ongoing initiatives (A. Segec)
Presentation - Emerging and innovative devices - state of play and key questions (J. Russo)
Presentation - Emerging and innovative therapies - state of play and key questions (O. Vedin)
Presentation - Challenges and opportunities in medicines development (A. Baczynska)
EMA/PE/0000232482
Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion under re-examination
Presentation - Challenges and opportunities in medicines and medical devices development (S. Dias)
Presentation - Adiposity: The gateway to cardiometabolic diseases (L. Fábryová)